|
|||||||||||
|
|||||||||||
| INstreet Link ARC Series 3 provides investors with the opportunity to access a $100,000 exposure in a systematic investment program with only $11,800 investment. The investment program aims to seek out trends and provide returns from both rises and falls in commodites markets. | |||||||||||
Key features and benefits | |||||||||||
|
Leveraged Exposure - By investing in Instreet Link ARC Series 3 investors are able to gain leveraged exposure to the price growth potential of Risk Stablised Aquantum Pegasus EL1 Index. Accessing $100,000 notional exposure for an $11,800 initial investment. The Aquantum Pegasus EL1 Index aims to deliver absolute returns with a low level of volatility.
Based on an extensive 12-year empirical analysis by RBS, the Index has recorded positive
returns every calendar year. Systematic investment process - 100% systematic and relying solely on computer driven trading, the Aquantum Pegasus EL1 Index identifies trends and exploits inefficiencies in commodity markets around the world. Strong Pedigree - Aquantum Algorithmic Limited is a specialist provider of absolute return strategies. Its principal,
Thomas Morrow, has been developing algorithmic trading strategies since the late 1980's with companies such as Bankers Trust, Deutsche Bank and Winton Capital before creating Aquantum. Low correlation with equity investments - It is widely accepted that due to the low correlation of returns with traditional equity portfolios, diversifying with a managed futures programs such as the Aquantum Pegasus Index can benefit investors overall performance. 2 bites at the cherry - Link ARC Series 3 resets the starting level at the end of year 1, allowing investors to receive a distribution of any gains or in the event of a loss, reset the 2nd year's starting point. | |||||||||||
Past Performance |
|||||||||||
![]() |
|||||||||||
Important Information |
|||||||||||
What do we get paid
Wealth Focus will rebate 37.5% of the 2% sales commission in the form of a cheque (0.75%). Wealth Focus does not receive a trailing commission for this product. Initial commission is paid by the product provider and is NOT an additional charge to the investor.






